CMND 投資分析
看多重點:
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足,尚無法提供評分
CMND 近期報酬表現
-0.78%
Clearmind medicine inc
1.56%
同產業平均
1.17%
S&P500
與 CMND 同產業的標的表現
股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
---|---|---|---|---|---|---|---|
CDT | Conduit pharmaceuticals inc | - | 2 分 | 2 分 | - | 1 分 | |
LXEO | Lexeo therapeutics inc | - | 3 分 | 4 分 | 3 分 | 1 分 | |
SNGX | Soligenix, incorporation | 5 分 | 2 分 | 4 分 | 1 分 | 1 分 | |
NEXI | Neximmune inc | 2 分 | 2 分 | 4 分 | 1 分 | 1 分 | |
SNTI | Senti biosciences inc | - | 3 分 | 4 分 | 1 分 | 1 分 |
- CDT Conduit pharmaceuticals inc價值 -趨勢 2 分波段 2 分籌碼 -股利 1 分查看更多
CMND 公司資訊
Clearmind Medicine Inc. Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company's intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.